scholarly journals The diagnostic value of basophil activation tests in hypersensitivity reactions due to contrast media

2021 ◽  
Vol 63 (4) ◽  
pp. 297-304
Author(s):  
Fevzi Demirel ◽  
Uğur Hacı Muşabak ◽  
Mustafa Güleç ◽  
Özgür Kartal ◽  
Sait Yeşillik ◽  
...  
BMJ Open ◽  
2020 ◽  
Vol 10 (3) ◽  
pp. e033023
Author(s):  
Hiroyasu Umakoshi ◽  
Takashi Nihashi ◽  
Hironori Shimamoto ◽  
Takehiro Yamada ◽  
Hiroaki Ishiguchi ◽  
...  

IntroductionIodinated contrast media are commonly used in medical imaging and can cause hypersensitivity reactions, including rare but severe life-threatening reactions. Although several prophylactic approaches have been proposed for severe reactions, their effects remain unclear. Therefore, we aim to review systematically the preventive effects of pharmacologic and non-pharmacologic interventions and predictors of acute, hypersensitivity reactions.Methods and analysisWe will search the PubMed, EMBASE and Cochrane Central Register of Controlled Trials databases from 1 January 1990 through 31 December 2019 and will examine the bibliographies of eligible studies, pertinent review articles and clinical practice guidelines. We will include prospective and retrospective studies of any design that evaluated the effects of pharmacological and non-pharmacological preventive interventions for adverse reactions of non-ionic iodinated contrast media. Two assessors will independently extract the characteristics of the study and intervention and the quantitative results. Two independent reviewers will assess the risk of bias using standard design-specific validity assessment tools. The primary outcome will be reduction in acute contrast media-induced hypersensitivity reactions. The secondary outcomes will include characteristics associated with the development of contrast media-induced acute hypersensitivity reactions, and adverse events associated with specific preventive interventions. Unique premedication regimens (eg, dose, drug and duration) and non-pharmacological strategies will be analysed separately. Average-risk and high-risk patients will be considered separately. A meta-analysis will be performed if appropriate.Ethics and disseminationEthics approval is not applicable, as this will be a secondary analysis of publicly available data. The results of the analysis will be submitted for publication in a peer reviewed journal.PROSPERO registration numberCRD42019134003


Author(s):  
Juliana Schwaab ◽  
Knut Brockow ◽  
Philipp Riffel ◽  
Johannes Lübke ◽  
Nicole Naumann ◽  
...  

2012 ◽  
Vol 108 (3) ◽  
pp. 167-171 ◽  
Author(s):  
Min-Hye Kim ◽  
Chang-Han Park ◽  
Duk-In Kim ◽  
Kyung-Mook Kim ◽  
Hui-Kyu Kim ◽  
...  

2014 ◽  
Vol 4 (S3) ◽  
Author(s):  
Daniela Rivero Paparoni ◽  
Ana Fiandor ◽  
Rosario Cabañas ◽  
Hoi Yan-Tong ◽  
Elena Ramirez ◽  
...  

2015 ◽  
Vol 10 (11-12) ◽  
pp. 269-273
Author(s):  
Zeljko Plazonic ◽  
Tanja Batinac ◽  
Marija Bukvic

Sign in / Sign up

Export Citation Format

Share Document